Wntrix Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Wntrix General Information


Developer of antibody drugs. The company develops medicines which combines capabilities of monoclonal antibodies with the cancer-killing ability of cytotoxic drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 26 Glowing Star Place
  • The Woodlands, TX 77382
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Wntrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 02-Mar-2016 Completed Startup
To view Wntrix’s complete valuation and funding history, request access »

Wntrix Executive Team (1)

Name Title Board Seat Contact Info
Qingyun Liu President & Director
To view Wntrix’s complete executive team members history, request access »

Wntrix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
To view Wntrix’s complete investors history, request access »